Monika Vainorius, MD
About Monika Vainorius, MD
Monika Vainorius, MD, serves as the Vice President of Clinical Development at CytomX Therapeutics, a position she has held since 2022. With extensive experience in clinical research and data management, she has contributed to various institutions including the University of North Carolina at Chapel Hill and Precision BioSciences, Inc.
Work at CytomX Therapeutics
Monika Vainorius serves as the Vice President of Clinical Development at CytomX Therapeutics since 2022. In this role, she oversees clinical development strategies and operations. Previously, she held the position of Executive Medical Director at CytomX Therapeutics for four months in 2022. Her work at CytomX focuses on advancing innovative therapies and ensuring compliance with regulatory standards.
Education and Expertise
Monika Vainorius earned her Medical Doctor (MD) degree from Kaunas Medical University, completing her studies from 1992 to 1999. She also holds a High School Diploma from Kaunas Dariaus ir Gireno Gimnazija. Her expertise encompasses late-stage, observational, and investigator-initiated studies, along with a strong foundation in data management and biostatistics. Vainorius has significant experience in strategic Key Opinion Leader (KOL) engagement and interactions.
Background
Monika Vainorius has a diverse professional background in clinical research and development. She worked at the University of North Carolina at Chapel Hill in various roles, including Director of Biometrics and Data Quality and Assistant Director of the Data Coordinating Center for HCV-TARGET. Her previous positions also include roles at Precision BioSciences, Inc. and Duke University, where she served as a Post-doctoral Fellow.
Achievements
Throughout her career, Monika Vainorius has collaborated with the FDA on multiple occasions, demonstrating her understanding of regulatory processes. She has also engaged with patient advocacy groups, reflecting her commitment to patient-centered approaches. Her extensive experience in clinical development and data management has contributed to her leadership roles in various organizations.